PANACEA BIOTEC
Back to Balance Sheet
|
PANACEA BIOTEC Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹99 Cr | ₹85 Cr | ₹960 Cr | ₹741 Cr | ₹70 Cr |
What is the latest Total Non-Current Liabilities ratio of PANACEA BIOTEC ?
Year | Total Non-Current Liabilities |
---|---|
Mar2023 | ₹99 Cr |
Mar2022 | ₹85 Cr |
Mar2021 | ₹960 Cr |
Mar2020 | ₹741 Cr |
Mar2019 | ₹70 Cr |
How is Total Non-Current Liabilities of PANACEA BIOTEC Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹99 Cr | 16.60 | |
Mar2022 | ₹85 Cr | -91.14 | |
Mar2021 | ₹960 Cr | 29.61 | |
Mar2020 | ₹741 Cr | 956.86 | |
Mar2019 | ₹70 Cr | - |
Compare Total Non-Current Liabilities of peers of PANACEA BIOTEC
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
PANACEA BIOTEC | ₹849.3 Cr | -2.9% | 2.7% | 14.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹367,026.0 Cr | 0.5% | -5.7% | 55.1% | Stock Analytics | |
CIPLA | ₹114,925.0 Cr | 1.1% | -4.4% | 55.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹105,128.0 Cr | -0.7% | 9.4% | 21.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,109.0 Cr | 0.1% | 1.1% | 28.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹102,736.0 Cr | 6% | 2.8% | 93.1% | Stock Analytics |
PANACEA BIOTEC Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
PANACEA BIOTEC | -2.9% |
2.7% |
14.1% |
SENSEX | 0.2% |
-0.2% |
20.9% |
You may also like the below Video Courses